Page last updated: 2024-08-16

ici 204,219 and piracetam

ici 204,219 has been researched along with piracetam in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bahnasawy, NH; Elnoby, AS; Fayez, AM; Hassan, O1

Other Studies

2 other study(ies) available for ici 204,219 and piracetam

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Neuroprotective effects of zafirlukast, piracetam and their combination on L-Methionine-induced vascular dementia in rats.
    Fundamental & clinical pharmacology, 2019, Volume: 33, Issue:6

    Topics: Acetylcholine; Animals; Brain; Brain Chemistry; Dementia, Vascular; Drug Therapy, Combination; Indoles; Interleukin-6; Male; Methionine; Neuroprotective Agents; Phenylcarbamates; Piracetam; Rats; Rats, Wistar; Sulfonamides; Tosyl Compounds

2019